Enanta Pharmaceuticals, Inc. (ENTA)
13.51
-0.49
(-3.50%)
USD |
NASDAQ |
Feb 20, 16:00
13.65
+0.14
(+1.04%)
After-Hours: 20:00
Enanta Pharmaceuticals Shareholders Equity (Quarterly) : 126.59M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agios Pharmaceuticals, Inc. | 1.193B |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 94.39M |
| BioMarin Pharmaceutical, Inc. | 6.057B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 329.50M |
| Total Liabilities (Quarterly) | 202.91M |
| Debt to Equity Ratio | 1.526 |
| Current Ratio | 4.442 |
| Net Debt Paydown Yield | 1.44% |